Lindsey Enewold
Biographic Data
| ID | 5539159 |
|---|---|
| NAME | Lindsey Enewold |
| GIVEN NAMES | Lindsey |
| FAMILY NAME | Enewold |
| SIGNATURE | ENEWOLD L |
| AFFILIATIONS | National Cancer Institute/DCCPS, Bethesda, MD |
| ORCID | 0000-0003-0452-5771 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2017 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Accuracy of Cancer Registry Primary Payer Information and Implications for Policy Research
BACKGROUND: Cancer registry-based "primary payer at diagnosis" (PPDx) data are commonly used to evaluate the effect of insurance on cancer care outcomes, yet little is known about how well they capture Medicaid or Medicare enrollment. METHODS: We linked the National Cancer Institute's Surveillance, Epidemiology, and End Results registry data to monthly Centers for Medicare and Medicaid Services (CMS) Medicaid and Medicare enrollment records, stat…
Evaluation of the Completeness of Managed Care Data to Identify Cancer Diagnoses and Treatments for Patients in the Seer-Medicare Data
BACKGROUND: The utility of codes on Medicare Advantage (MA) data to capture cancer diagnoses and treatment for cancer patients is unknown. OBJECTIVE: This study compared cancer diagnoses and treatments on MA encounter data (MA data) with the Surveillance, Epidemiology, and End-Results (SEER) data. SUBJECTS: Subjects were patients enrolled in either MA or Medicare fee-for-service (MFFS) when diagnosed with incident breast, colorectal, prostate, or…
Creating a National Provider Identifier (NPI) to Unique Physician Identification Number (Upin) Crosswalk for Medicare Data
INTRODUCTION: Many health services researchers are interested in assessing long term, individual physician treatment patterns, particularly for cancer care. In 2007, Medicare changed the physician identifier used on billed services from the Unique Physician Identification Number (UPIN) to the National Provider Identifier (NPI), precluding the ability to use Medicare claims data to evaluate individual physician treatment patterns across this trans…
No prominent works on this page.
Creating a National Provider Identifier (NPI) to Unique Physician Identification Number (Upin) Crosswalk for Medicare Data
INTRODUCTION: Many health services researchers are interested in assessing long term, individual physician treatment patterns, particularly for cancer care. In 2007, Medicare changed the physician identifier used on billed services from the Unique Physician Identification Number (UPIN) to the National Provider Identifier (NPI), precluding the ability to use Medicare claims data to evaluate individual physician treatment patterns across this trans…
Evaluation of the Completeness of Managed Care Data to Identify Cancer Diagnoses and Treatments for Patients in the Seer-Medicare Data
BACKGROUND: The utility of codes on Medicare Advantage (MA) data to capture cancer diagnoses and treatment for cancer patients is unknown. OBJECTIVE: This study compared cancer diagnoses and treatments on MA encounter data (MA data) with the Surveillance, Epidemiology, and End-Results (SEER) data. SUBJECTS: Subjects were patients enrolled in either MA or Medicare fee-for-service (MFFS) when diagnosed with incident breast, colorectal, prostate, or…
Accuracy of Cancer Registry Primary Payer Information and Implications for Policy Research
BACKGROUND: Cancer registry-based "primary payer at diagnosis" (PPDx) data are commonly used to evaluate the effect of insurance on cancer care outcomes, yet little is known about how well they capture Medicaid or Medicare enrollment. METHODS: We linked the National Cancer Institute's Surveillance, Epidemiology, and End Results registry data to monthly Centers for Medicare and Medicaid Services (CMS) Medicaid and Medicare enrollment records, stat…
Epidemiology (3 works) · Epidemiology (3 works) · Global Cancer Incidence and Screening (3 works) · Internal Medicine (3 works) · Internal Medicine (3 works) · Medicine (3 works) · Cancer registry (2 works) · Economic and Financial Impacts of Cancer (2 works) · Family medicine (2 works) · Breast cancer (1 work)